Meridian Bioscience reported $210.6M in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Accelerate Diagnostics AXDX:US USD 66.27M 18.21M
Atrion ATRI:US USD 137.57M 1M
Becton, Dickinson and BDX:US USD 8.14B 1.41B
Bio Rad Laboratories BIO:US USD 3.14B 109.54M
Cerus CERS:US USD 164.73M 59K
Meridian Bioscience VIVO:US USD 210.6M 1.87M
Myriad Genetics MYGN:US USD 352.3M 14.8M
Orasure Technologies OSUR:US USD 279.73M 12.43M
Sientra SIEN:US USD 108.54M 9.43M
Staar Surgical STAA:US USD 296.91M 454K
Thermo Fisher Scientific TMO:US USD 19.3B 1.2B
Utah Medical Products UTMD:US USD 84.24M 5.29M